Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Advenchen Laboratories LLC
DescriptionProtein tyrosine kinase inhibitor
Molecular Target Vascular endothelial growth factor (VEGF) receptor ; Fibroblast growth factor (FGF) receptor (FGFR)
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today